This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignees: European Molecular Biology Laboratory, F. Hoffmann-La Roche Ag, Savira Pharmaceuticals Gmbh. Active years: 2016.
Company Filing History:
1 out of 79 
1 out of 180 
1 out of 8 Years Active: 2016
Title: Céline Simon: Innovator in Viral Disease Treatment
Introduction
Céline Simon is a notable inventor based in Illkirch, France. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of viral diseases. His innovative work has led to the development of a unique compound that holds promise for medical applications.
Latest Patents
Céline Simon holds 1 patent for his invention titled "7-oxo-thiazolopyridine carbonic acid derivatives and their use in the treatment, amelioration or prevention of a viral disease." This patent describes a compound with a general formula (A), which may exist in various forms such as pharmaceutically acceptable salts, solvates, polymorphs, codrugs, cocrystals, prodrugs, tautomers, racemates, enantiomers, or diastereomers. The compound is designed to be effective in treating, ameliorating, or preventing viral diseases, and it also discloses specific combination therapies.
Career Highlights
Throughout his career, Céline Simon has worked with prominent companies in the pharmaceutical industry. Notably, he has been associated with Savira Pharmaceuticals GmbH and F. Hoffmann-La Roche AG. His work in these organizations has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Céline Simon has collaborated with esteemed colleagues, including Andrea Wolkerstorfer and Oliver Szolar. These partnerships have fostered innovation and have been instrumental in the progress of his research and development efforts.
Conclusion
Céline Simon's contributions to the field of viral disease treatment through his innovative patent and collaborations with leading pharmaceutical companies highlight his role as a significant inventor. His work continues to pave the way for advancements in medical science.